Background/Aim: MicroRNAs with regulatory functions in gene expression are implicated in different diseases. The present study investigated differentially expressed miRNAs that possibly influence transcription factors involved in insulin gene expression in Chronic Pancreatitis (CP) employing bioinformatics approaches. Methods: Pancreatic tissues were collected from CP patients undergoing partial pancreatectomy (n = 16) and controls (n = 15) undergoing resections for non-pancreatic malignancies. MiRNA profiles obtained using microarrays were validated by qRT-PCR. Target search involving miRWalk and TarBase as well as functional annotation employing KEGG (Kyoto encyclopedia of genes and genomes) and DAVID (Database for Annotation) databases were performed. Ingenuity pathway analysis (IPA) was used to construct networks relating miRNAs to their target genes. mRNA and proteins related to insulin gene transcription factors and hormones were evaluated by qRT-PCR and western blotting followed by confirmation upon immunofluorescent staining. Results: Microarray data revealed 10 up-regulated and 15 down-regulated miRNAs in CP as compared to controls (Log2 FC > 2). Bioinformatic analysis showed 8399 target genes and KEGG pathway analysis suggested a role for the dysregulated miRNAs in modulating cytokine signaling, fibrosis, JAK-STAT signaling and insulin synthesis. IPA analysis suggested a simplified network attributing dysregulated miRNAs to NFκB-dependent cytokine signaling. 
Introduction
Chronic pancreatitis (CP) is a progressive inflammatory disorder ultimately culminating in exocrine and endocrine insufficiency contributing to associated maldigestion, abdominal pain and clinical diabetes. Endocrine insufficiency and clinical diabetes are popularly believed to occur as a result of fibrosis and β-cell destruction (apoptosis) in CP [1] . Several investigators demonstrated insulin secretory defects in patients with long standing CP [2] . It is held that insulin secretory defects arise initially as a result of β-cell dysfunction and overt clinical diabetes manifests from β-cell destruction much later in the course of the disease. Such findings suggested a need to study the mechanism of β-cell dysfunction under conditions of chronic inflammation in CP. Diabetes mellitus, secondary to chronic pancreatitis, is now categorized as Type 3C DM [3] . The complex pathophysiology of CP involving secondary diabetes presents distinct clinical and laboratory features, in contrast to autoimmunity and insulin resistance associated respectively with Type 1 and Type 2 DM. Currently it is reported that 5% -10% in western population and 15% -20% of diabetics in South East Asia have Type 3C DM [4] . Despite vast knowledge on Type 1 and Type 2 DM, Type 3C diabetes is relatively the less studied form of diabetes. Interestingly, our earlier reports demonstrated reduced islet response to glucose stimulation even in non-diabetic CP patients [5] .
MicroRNAs are small, endogenously expressed noncoding RNAs (~21 -25 nucleotides) known to influence basic cellular functions by regulating gene expression. miRNAs bind to the 3'-untranslated region of mRNAs and lead to either transcriptional repression or mRNA degradation [6] [7] . Altered miRNA profiles have been implicated in different diseases such as diabetes, inflammatory diseases and various malignancies [8] [9] [10] . A few studies have also established basic functional role of miRNAs in islets (hormone secreting cell clusters) including miRNA375 in islet development, miRNA9 in regulating insulin secretory response, miRNA124 in regulating intracellular signaling and miRNA30d in induction of insulin production by targeting MAP4K4 [11] [12] [13] [14] . Further, it was shown that miRNA21, 34a and 146 act as negative regulators of insulin signaling [15] . Increased expression of miRNA29 family in pre-diabetic NOD mice was shown to be associated with cytokine mediated β-cell dysfunction [16] .
Islet response to circulating nutrients involves tight coordination and regula-tion between synthesis and secretion of pancreatic hormones. Expression of insulin gene in response to secretagogues is known to be controlled by various transcription factors such as Pdx1, neuro D, Maf A that bind to enhancer elements in the promoter region of insulin gene [17] . Even though several investigators have reported altered miRNA profiles in CP and pancreatic cancer [18] , relatively much less is known about the influence of aberrant miRNA(s) on β-cell function in CP; putative interactions between miRNAs and mRNAs of transcription factors of insulin gene expression have also not been elucidated under inflammatory conditions of CP. The established role of miRNAs in inflammation [9] as well as the reported role of miRNAs in β-cell dysfunction in Type 2 DM [19] and in prediabetic NOD mice [16] have led us to hypothesize that aberrant miRNA expression in CP may also have an effect on insulin gene transcription, which may contribute to β-cell dysfunction.
The present study was thus conducted to (a) evaluate altered pattern of miRNAs in CP and identify their putative targets including genes coding for islet hormones and associated transcription factors; (b) identify association of aberrant miRNAs with signaling pathways involved in insulin gene expression and establish possible network(s) between miRNAs and target genes in CP using bioinformatics approaches.
Patients and Methods
Patients: Pancreatic tissues were obtained either from CP patients (n = 16) who had undergone partial pancreatectomy/lateral pancreaticojejunostomy for pain relief or from patients who had undergone pancreaticoduodenectomy for ampullary/periampullary pathology without any history of CP (controls; n = 15), Histological confirmation of CP involved H&E staining of the resected specimens by a single pathologist experienced in pancreatic pathology who was blinded to the patient groups. Patients with CP having pancreatic malignancies, endocrine tumors, acute on CP were excluded. The study was initiated after the protocols were approved by the Institutional Ethics Committee of Asian Institute of Gastroenterology and all the patients had given informed consent.
MicroRNA profiling and validation of dysregulated miRNAs
Total RNA from the pancreatic tissues was extracted and purified using miRvana RNA isolation kit following the manufacturer's instructions (Applied Biosystems/Ambion, Austin, TX). Qualitative and quantitative assessment of total RNA was obtained using Agilent 2100 bioanalyzer as per the prescribed protocol of the manufacturer (Agilent Technologies, USA). Good quality RNA samples with RNA Integrity Number (RIN) > 7 were subjected to microarray analysis for miRNA profiling and to qRT-PCR for validation of identified miRNA. Micro-RNA profiling, microarray data analysis and validation with qRT-PCR were performed as described earlier [20] . The raw data were submitted to the ArrayExpress database (accession ID: E -MTAB-3882).
Target gene prediction and pathway analysis of dysregulated miRNAs
Putative target genes for the differentially expressed miRNAs were identified and retrieved from miRWalk 2.0 database [21] , which compiles and compares the predictions of other databases. Target genes that were experimentally validated for dysregulated miRNAs were retrieved from Diana Lab Tarbase v.6 [22] .
The putative and validated targets of dysregulated miRNAs were subjected to KEGG pathway annotation using DAVID functional annotation tool [23] water. Samples were run in duplicates and data were normalized to human GAPDH. mRNA levels were relatively quantified by using ΔΔCT method (List of used Primers is given in Supplementary Table S1 ).
Western blot analysis and immunofluorescent staining for expression of Pdx1, Neuro D and MafA Proteins were isolated from minced pancreatic tissue using 500 μl of RIPA lysis buffer with protease cocktail inhibitor (Sigma Aldrich, St Louis, USA) and probing the western blots either with rabbit anti-Pdx1 or rabbit anti-NeuroD or rabbit anti-MafA (Invitrogen, Shanghai, China) or anti β-actin (Santa cruz Biotechnology, USA) as per standard protocols [24] . Statistical analysis: The data were analyzed using statistical package for social sciences (SPSS version 20.0, Chicago, USA). A two tailed students P value of < 0.05 was considered statistically significant. qRT-PCR analysis corroborated microarray miRNA expression profiles in CP Microarray data identifying the three up-regulated miRNAs (miR-138, miR-767, Glucose responsive MafA expression increased and Pdx1, Neuro D expression decreased in CP mRNA levels of the transcription factors of insulin gene were noted to be al- E2F4, ACVRL1, E2F5, LOC100271831, GDF5,  TGFB3, RPS6KB2, RPS6KB1, ACVR1C, ACVR1B,  CDKN2B, ZFYVE9, ZFYVE16, LOC643778, IFNG,  MYC, PITX2, PPP2R1B, ROCK1, RBL2, ROCK2, SKP1,  INHBB, MAPK1, INHBA, ACVR2A, ACVR2B, EP300,  MAPK3, INHBC, ACVR1, BMPR2, DCN, PPP2CA,  THBS1, THBS2, TFDP1, BMP2, SMAD9, SMAD7,  SMAD6, TGFBR1, CREBBP, TGFBR2, SMAD4,  SMAD2, SMAD1, SP1, ID2, ROCK1P1, ID1, SMURF2,  ID4, SMURF1, ID3, BMPR1B, BMP7, CHRD, BMP8B 
Results

Clinical characteristics of patients
Discussion
Micro RNAs are known to play a pivotal role in controlling basic cellular functions by regulating gene expressions. We conducted this study to explore whether there is any dysregulation of pancreatic miRNAs under the inflammatory conditions prevalent in CP and to identify putative links between differentially expressed miRNAs and transcription factors that coordinately regulate insulin gene expression contributing to secondary diabetes occurring in the disease. Our results demonstrate a network of three miRNAs (miR200b, 138 and 27b) regulating insulin gene transcription factors along with cytokines in CP.
The dysregulated profiles of miRNA obtained on microarray and validated on qRT-PCR indicate that inflammation in CP is associated with altered miRNA expression. The observed expression profiles of dysregulated miRNA in the present studies were similar to earlier studies which examined miRNA patterns in the progression of chronic pancreatitis to pancreatic ductal adenocarcinoma [18] which reported up-regulation of miR-339 and down-regulation of miR-34, miR-181, miR-375, miR125b and miR-99. Further, the down regulation patterns (Supplementary Table S3 ) were akin to those reported in a study comparing the abundance of circulating and tissue miRNAs in CP [25] . Subtle differences [30] . In addition, Wang et al. showed that the miR-200 cluster (mir200 a, b and mir141) contributes directly to fibrosis by regulating of TGF-β2 [31] . Reporter gene assays have also confirmed TGF-β2 to be the direct target of miR-141/miR-200a [32] . Our results are in agreement with these studies suggesting that down regulation of miR200 and miR29 may be contributing to fibrosis in CP [33] . Decreased expression of miR-216/217 cluster which has been shown to be involved in EMT also suggests its role in fibrogenesis [34] . Decreased expression of miRNA-27 cluster is known to target PPARγ ligand, which modulates NF-κB dependent pro-inflammatory cytokine production and pancreatic stellate cell activation [35] ; this in turn would contribute to increased oxidative stress and inflammation in CP. It is noteworthy that evidences are increasingly indicating that prolonged oxidative stress may be a contributing factor for pathogenesis and progression of CP [36] . Results of the present study as well as an earlier report by our group [37] also denote down-regulation of miR-30 family in CP; the miR-30 family is implicated in induction of insulin synthesis by targeting MAP4K4 regulation [38] [39] [40] these observations indicate that miRNA clusters might play a crucial role in inflammation, fibrosis and aberrant β-cell functions associated with CP.
Although comprehensive search was conducted for target gene prediction, networks were generated restricting the analysis to target genes that are associated with oxidative stress, cytokine signaling, Inflammation and insulin signaling since they are highly relevant to the progression of CP and manifestation type 3CDM. An attempt was also made to understand the intricate relations between the dysregulated miRNAs, target genes, and β-cell dysfunction in CP employing Ingenuity Pathway Analysis. A curated network was generated involving miRNAs, target genes of cytokine signaling, oxidative stress, insulin synthesis, β cell function. Interestingly, the resultant network revealed a web consisting of various proinflammatory cytokines (IL6, IFNγ, IL1β, and TNFα), JAK2, NFκB signaling pathways, statins (STAT1 and STAT3), effectors of β-cell function (MafA, NeuroD and Pdx1), β-cell development (MafB), β cell oxidative stress protective transcription factor (FoxO1) and insulin. Earlier results from our laboratory and that of others have shown increased expression of proinflammatory cytokines [41] in CP and a role for NFκB [42] and oxidative stress was implicated in the inflammation in CP [43] . The network established in the present study has also identified links between cytokines and miRNAs (IL6 -miR191; [47] . FoxO1 and Pdx1 have also been reported to show mutually exclusive nuclear localization [48] [49] [50] . Increased oxidative stress, arising from inflammation and decreased miR 27b could result in raised FoxO1 and diminished Pdx1 expression in CP as observed in this study could be due to raised FoxO1. Transgenic mice with FoxO1 gain of function in the pancreas exhibited glucose intolerance [51] . Conversely, FoxO1 ablation in β-cells resulted in increased insulin secretion [52] . Further, in vitro studies showed suppression of miRNA-27 resulted in increased FoxO1 protein levels and a consequent decrease in cell number [53] . Hence we believe that increased 
Conclusion
In summary, present study identified dysregulated miRNAs and indicated the Figure S1. Number of mRNA transcripts identified by miRwalk for each differentially expressed miRNA.
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